TSE:4547Pharmaceuticals
Kissei Pharmaceutical (TSE:4547) One Off ¥18.5b Gain Complicates Bullish Earnings Narrative
Kissei Pharmaceutical (TSE:4547) has put up another solid quarter, with Q3 2026 revenue of ¥26,802 million and basic EPS of ¥77.92. Trailing twelve month EPS sits at ¥337.35 on revenue of ¥95,294 million and net income of ¥14,135 million. Over recent quarters the company has seen revenue move from ¥23,203 million in Q3 2025 and ¥22,661 million in Q4 2025 to ¥22,191 million in Q1 2026 and ¥23,640 million in Q2 2026. Over the same stretch, EPS ranged from ¥25.86 to ¥107.87, setting up a picture...